Table 1 Antibiotic resistance profile and biofilm formation of strain C-214.

From: Genomic and phenotypic characterization of Acinetobacter colistiniresistens isolated from the feces of a healthy member of the community

Strain:

C-214

Antibiotics

Interpretive categories, zone diameter, breakpoints

Results zone diameter (mm), breakpoints

S

I

R

AST

PRL 100

 ≥ 21

18–20

 ≤ 17

21

S

TZP 110

 ≥ 21

18–20

 ≤ 17

26

S

SAM 20

 ≥ 15

12–14

 ≤ 11

18

S

CAZ 30

 ≥ 18

15–17

 ≤ 14

18

S

CTX 30

 ≥ 23

15–22

 ≤ 14

13

R

FEP 30

 ≥ 18

15–17

 ≤ 14

23

S

IPM 10

 ≥ 22

19–21

 ≤ 18

30

S

MEM 10

 ≥ 18

15–17

 ≤ 14

27

S

CN 10

 ≥ 15

13–14

 ≤ 12

20

S

AK 30

 ≥ 17

15–16

 ≤ 14

12

R

CIP 5

 ≥ 21

16–20

 ≤ 15

28

S

TE 30

 ≥ 15

12–14

 ≤ 11

10

R

MIC

Colistin

(µg/ml)

 ≥ 2

–

 ≤ 4

32

R

Polymixin B

(µg/ml)

 ≥ 2

–

 ≤ 4

16

R

Biofilm

XTT

Moderate

 

CV

Moderate

  1. C community isolates; R resistant; S susceptible; I intermediate; PRL100 piperacillin 100 µg; TZP110 piperacillin-tazobactam 110 µg; SAM20 ampicillin/sulbactam 20 µg; CAZ30 ceftazidime 30 µg; CTX30 Cefotaxime 30 µg; FEP30 cefepime 30 µg; IPM10 imipenem 10 µg; MEM10 Meropenem 10 µg; CN10 gentamicin 10 µg; AK30 Amikacin 30 µg; CIP5 ciprofloxacin 5 µg; TE30 tetracycline 30 µg.